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ABSTRACT 
 
Aim: Both Cathelicidin and Chemerin are chemo-attractant proteins and possess antimicrobial 
activity. Sufficient level of Vitamin D is important for optimum response of Cathelicidin for its anti-
mycobacterial activity. Studies on the role of these antimicrobial peptides and their relationship with 
Vitamin D level are limited in tuberculosis. The aim of this study was to investigate an association 
of Vitamin D with antimicrobial peptide (Cathelicidin) and an adipokine (Chemerin) in patients with 
pulmonary tuberculosis (TB).  
Methods: In a case control study we estimated level of Vitamin D, Chemerin, Cathelicidin and TNF 
α in pulmonary TB patients (n=22) and healthy endemic controls (n=17) using sandwich ELISA 
methodology. The study was conducted at Aga Khan University Karachi during 2011. 
Results: TB group had higher proportion of subjects above median level of Cathelicidin (median 
test; p=0.034) and fewer number of subjects with Chemerin (median test; p=0.001). Pairwise 
comparison also showed significant differences between average ranks of Vitamin D vs. 
Cathelicidin (p<0.0001), Chemerin vs. Cathelicidin (p=0.04) and Vitamin D vs. TNFα (p<0.0001).  
Cathelicidin was identified as most discriminatory marker between TB disease and healthy group 
(ROC, AUC 0.780; p=0.007). 
Conclusion: Our results highlight the role of Cathelicidin as a potential biomarker of active TB 
disease.  The role of Cathelicidin and Chemerin as plausible biomarkers requires further studies in 
both inflammatory and non-inflammatory conditions.  
 
 
Keywords: Tuberculosis; vitamin D; cathelicidin; chemerin. 
 
1. INTRODUCTION  
 
Tuberculosis (TB) is the leading cause of 
mortality and morbidity in developing world. In 
2012, 0.5 million new incident cases were 
reported in Pakistan with an incidence of 
231/100,000 population [1]. Pakistan ranks 6th 
among 22 highest TB burden countries [1].  
Profound Vitamin D deficiency has been reported 
among new incident TB cases [2] and healthy 
volunteers in Pakistan [3]. Sufficient level of 
Vitamin D is important for macrophage activation 
for antimicrobial response [4]. The mechanism of 
activation of macrophages via Vitamin D pathway 
for anti-mycobacterial activity has already been 
delineated [5]. The stimulation of Toll like 
receptors (TLRs) on macrophages results in 
activation of Cathelicidin gene (hCAP18) by 1-
hydroxylase enzyme gene (CYP27B1) [6] to 
convert inactive Vitamin D [25(OH)D3] in to 
active form [1,25-(OH)2D3].  A limited number of 
studies have shown relationship of circulating 
levels of inactive Vitamin D [25(OH)D3] and 
Cathelicidin  in clinical studies, such as TB [7] 
and sepsis [8]. Cathelicidin family of peptides are 
23-40 amino acid long chain with helical 
structure. Cathelicidin possess antimicrobial 
property because of its amphipathic topology and 
presence of negatively charged residue. 
Cathelicidin also up-regulates chemokine 
receptors on macrophages [9] and is involved in 
migration of immune cells to the site of infection.  
Antimicrobial effect of Cathelicidin is very well 
studied against M. tuberculosis (M.tb) [10]. 
However, the anti-mycobacterial effect of 
Chemerin is not fully discovered. Chemerin is a 
non-glycosylated 16 kDa protein secreted as 
precursor of 143 amino acid residues known as 
Prochem 163S. This multifunctional protein 
primarily known for its adipokine and chemotactic 
activity for immune cells [Plasmacytoid (PDCs), 
NK and Macrophages)]. Proteolytic cleavage of 
pro-chemerin molecule by cathepsin results in 
formation of Chem 156 isoform which possess 
greater affinity for chemokine receptor like 1 
(CMKLR1). Chemerin is structurally similar to N 
terminus Cathelin domain of human Cathelicidin. 
The predominant function of Chemerin is glucose 
homeostasis [11,12]. Due to its involvement in 
regulation of immune cells and antimicrobial 
activity, it is intriguing to address the association 
of Chemerin with chronic inflammation such as 
TB.  Its association in diabetes and obesity has 
already been established [13].  In countries with 
high burden of TB, the rate of pre-diabetes and 
Diabetes Mellitus (DM) is 24-25% among newly 
diagnosed TB patients [14].  Animal models of 
DM have also shown phenomenon of delayed 
inflammatory response in granuloma formation 
after aerosol challenge of M.tb [15,16]. The 
relationship of low serum Vitamin D with 
incidence of DM [17] has significantly move the 
field to study the association of DM co-infected 
with TB [18,19]. It is hypothesized that low serum 
Vitamin D may promote pro-inflammatory 
cytokines milieu which is favorable for 
progression of TB with or without comorbidity of 
DM. It is therefore interesting to understand the 
complex relationship of Chemerin (marker of 
obesity and Diabetes) with Cathelicidin and 
Vitamin D in TB patients. This relationship is 
described in a conceptual diagram in Fig. 1.
 
The aim of our study is to assess the relationship 
of two related chemoattractant peptides, 
Cathelicidin and Chemerin with Vitamin D and 
pro-inflammatory cytokine (TNFα) in TB cases 
and healthy controls.   
 
2. MATERIALS AND METHODS 
 
2.1 Study Design 
 
Twenty two (n=22) pulmonary TB patients (TB) 
were recruited from The Aga Khan University 
and Abbasi Shaheed Hospital outpatient clinics 
in this case control study. The chest physicians 
at both hospitals identified and referred the 
pulmonary TB patients as per study inclusion and 
exclusion criteria. Pulmonary disease was 
 
 
 
Fig. 1. Conceptual diagram of hypoth
Low vitamin D i.e less than 20 ng/ml (A) triggers a pro
inflammatory state (B). Reactivation of latent TB infec
Th2 cytokines axis may lead to progression of active disease (C), which is represented by elevated level of 
Cathelicidin. Chronic inflammatory state may lead to dia
indicated by increase Chemerin level. 
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confirmed by chest X-ray, Acid Fast Bacilli (AFB) 
sputum microscopy and history of TB symptoms.  
Majority of TB patients had moderate (PMD) 
(n=9) and, advanced (PAD) (n=7) pulmonary 
disease, two patients were characterized as 
minimal disease (PMD) and information was not 
available for 3 patients. The severity of disease 
classification was based on radiological findings, 
and extent of lung tissue involvement as per 
defined criteria [20]. Healthy endemic controls 
(EC; n=17) had no history of TB exposure and 
were recruited from administrative staff and 
research technologists of AKU research and 
teaching lab. 
 
Study protocol was approved by Ethical Review 
Committee (ERC) of Aga Khan University (
Path-ERC-10). All participants gave written 
informed consent. 
 
2.1.1 Inclusion criteria 
 
The inclusion criteria for TB group (n=22) were 
active pulmonary TB diagnosed as per WHO 
guidelines [21] within one month of treatment.
 
etical relationship between vitamin D, 
Cathelicidin and Chemerin 
-inflammatory cytokine milieu, which leads to chronic 
tion due to immunosuppression and disturbance of Th1 and 
betes mellitus with or without co-incident TB (D) which is 
The dashed arrow shows the relationship of Vitamin D to 
and Cathelicidin 
 
 
 
 
BJMMR.2015.368 
 
 
1689-
 
 
 
Chemerin  
 
 
 
 
Iqbal et al.; BJMMR, 7(7): 611-622, 2015; Article no.BJMMR.2015.368 
 
 
 
614 
 
2.1.2 Exclusion criteria 
 
Patients with treatment relapse or past TB 
history, extra-pulmonary TB and known MDR TB 
were not included in the study. TB patients with 
prior or current Vitamin D 
supplementation/injections, co-morbid conditions 
such as DM, malignancies or auto immune 
diseases were also excluded from the study.  
 
Seventeen healthy controls were employees of 
AKU. The inclusion criteria for healthy controls 
(n=17) were no current or past TB diagnosis/DM/ 
chronic infections and no current or prior 
intervention with Vitamin D. Healthcare workers 
and lab staff directly exposed to TB were also 
excluded.  
 
2.2 Collection of Blood for Plasma and 
Whole Blood Stimulation Assays 
 
Five ml blood was collected in 15 ml of conical 
tube (BD Falcon) containing sodium heparin (20 
U/ml; Leo Pharmaceuticals, Ballerup, Denmark). 
Heparinized blood was diluted 1:4 with RPMI 
1640 (supplemented with Pen/Strep, 2 mM L-
Glutamine) for use in stimulation assays.  Two ml 
of blood was collected separately in EDTA tube 
and centrifuged for 5 minutes at 2000 x g to 
separate clear portion i.e. plasma within 2hrs of 
collection.  Plasma was stored in small aliquots 
and kept at -70ºC until further use.  
 
2.2.1 Preparation of active vitamin D [1, 25-
(OH) 2D3] for In vitro experiments 
 
The 1, 25- (OH) 2D3 Vitamin D was purchased 
from Sigma Chemicals (Sigma, St. Louis, USA).  
The crystallized form of Vitamin D was dissolved 
in reagent grade ethanol (EtOH) (Merck 
laboratories).  A ten-fold higher working stock for 
each of the dilution was prepared to obtain a final 
concentration 0.1 µM in 500µl of whole blood 
cultures. The concentration of 1,25-(OH)2D3for 
invitro experiments were consistent with previous 
reports for stimulation of PBMCs [22] and 
lympho-proliferative responses [23]. 
 
2.2.2 Stimulation of whole blood with active 
vitamin D [1, 25-(OH) 2D3] for cytokine 
secretion in supernatants 
 
Stimulation of whole blood cultures with Vitamin 
D [1, 25-(OH) 2D3]. The whole blood cultures 
were stimulated with 0.1µMconcentration of 1, 
25-(OH) 2D3 (Sigma, St, Louis USA) in 24 well 
tissue culture plates (Flow laboratories, UK). 
Tissue culture plates (24 wells) were preloaded 
with 1, 25-(OH) 2D3 in 50µl volume. Ethanol was 
allowed to evaporate, leaving 1, 25-(OH) 2D3 in 
0.1µM concentration in a well followed by 500 µl 
of diluted whole blood. The control well for 
Vitamin D was EtOH (vehicle control).   
 
Supernatants collected at day 1 and day 3 post 
stimulation were stored as 4 x 100 microliters 
aliquots in -80°C until use. 
 
2.2.3 Assessment of cytokines (TNFα, IFN 
and IL10) in stimulated whole blood 
cultures and plasma 
 
Cytokine assessment was carried out using pairs 
of monoclonal antibodies from Endogen, 
Rockford IL, USA. Protocols for cytokine 
assessment have been described in detail 
elsewhere [24].  Briefly, Immulon4 plates were 
coated with capture antibodies overnight at 4°C. 
Next day plates were blocked with BSA and 
subsequently incubated with 100 µl of culture 
supernatant. Revealing and probing antibodies 
were added after appropriate incubation. All 
probing antibodies were labeled with biotin and 
revealing antibodies were labeled with avidin 
bound to horse radish peroxidase (HRP).  Finally 
plates were developed with HRP substrate.  All 
plates were read on plate reader (Biorad, CA, 
USA). Optical densities were read against known 
concentration of standards (1000 pg-7.8 pg.) of 
cytokines to determine the concentrations in test 
samples [24]. 
 
2.2.4 Estimation of inactive form of vitamin D 
[25(OH)D3] in plasma 
 
Baseline Vitamin D levels were assessed in 
plasma samples of TB patients and healthy 
controls. Circulating Vitamin D was measured by 
ELISA using the Immuno Diagnostic System Ltd 
[IDS, Fountain Hill, AZ, USA].  All protocols were 
followed according to manufacturer instructions. 
Each test was run in duplicate, with mean 
absorbance of test samples computed from the 
average for two wells normalized for 0 calibrator 
well. Concentrations of Vitamin D in test samples 
were derived by fitting a 2 parameter logistic 
curve to 6 standard concentrations, and was 
expressed as ng/ml (1 nmol/L * 0.4= 1 ng/ml) [2]. 
 
2.2.5 Estimation of Cathelicidin peptide by 
ELISA 
 
Estimation of Cathelicidin peptide was carried out 
by ELISA (Hycult Biotechnology, AA Uden The 
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Netherlands) assay in plasma samples. All 
protocols were followed according to 
manufacturer instructions. Each sample was run 
in duplicate. The minimum measurable 
concentration was between 0.1 ng/ml to up to 
100 ng/ml of Cathelicidin. The unknown 
concentration was derived by plotting 
absorbance of samples against known 
concentrations of standards. All standard curve 
has R2 greater than 0.90.  
 
2.2.6 Estimation of Chemerin peptide by 
ELISA 
 
Chemerin levels in plasma samples were 
determined using a commercially available 
sandwich ELISA kit (Glory Bioscience, USA, cat 
#11406). The inter-assay coefficient of variation 
was less than 10%, and the within-assay 
coefficient of variation was less than 5%. The 
sensitivity of the ELISA assay was 0.5–10 ng/ml, 
and the midrange of the assay was 5 ng/ml. The 
least detectable concentration of human 
Chemerin was 0.5 ng/ml. 
 
2.3 Statistical Methods 
 
Data was analyzed by statistical software of 
SPSS 19 and Microsoft Excel. Mann Whitney U 
test and Median test was applied for comparison 
of median difference in two groups. Friedman 
two way test was applied for comparison of ranks 
between two analytes. ROC analysis was carried 
out for identification of discriminatory marker 
between TB and EC groups. A p value <0.05 
was considered a significant between groups.  
 
3. RESULTS AND DISCUSSION 
 
3.1 Characteristics of the Study Groups 
 
TB group comprised of (54%) of male and (45%) 
female. The mean age of TB and EC groups 
were 25.136±8.697yrs (range 16-50yrs), and 
31.647±5.219yrs (24-46yrs) respectively. BCG 
scar was present in 27% of TB patients and up to 
90% in healthy controls. Overall incidence of HIV 
in TB cases is 0.96% in Pakistan [1]. TB patients 
were not screened for HIV positivity. 
 
3.2 Relationship of circulating level of 
Cathelicidin, Chemerin and Vitamin D 
in TB and EC Group 
 
The criteria for plasma Vitamin D [25(OH)D3] 
deficiency is based on international convention 
(reference plasma levels) (deficient = <20 ng/ml; 
insufficient =21-29 ng/ml; sufficient >30 ng/ml) 
[4]. A majority (71%; N= 28/39) of study 
participants had deficient Vitamin D levels [<20 
ng/ml of plasma 25(OH) D3]. 
 
Fig. 2 shows the comparison of Chemerin (Fig. 
2a), Cathelicidin (Fig. 2b) Vitamin D (Fig. 2c) and 
TNFα (Fig. 2d) between TB and EC groups in 
box plots. In TB group, the level of Chemerin was 
significantly lower compared to controls (p=0.02). 
The average weight of TB patients was 
41.22±3.77kg, and that of EC was 63.83±12.31 
kg (T test; p=0.00004). The lower level of 
Chemerin in TB group is presumably due to 
lower body weight or less adipocytes. 
 
We next compared the Cathelicidin and TNFα 
among TB and EC group, the level of 
Cathelicidin and TNFα are presumably higher in 
TB patients, although the medians are not 
significantly different. Cathelicidin and TNFα 
showed similar trends in box plots which were 
later confirmed by scatter plot that showed a 
linear relationship (Fig. 4). There was no 
difference in Vitamin D level between TB and EC 
group. 
 
In order to determine the pairwise comparison of 
biomarkers, we performed rank order analysis of 
whole study group to observe the trend of 
markers across the board. Table 1 shows the 
distribution of Cathelicidin, Chemerin and Vitamin 
D using rank order test. The average rank for 
Cathelicidin was 2.49 followed by 1.95 in 
Chemerin and 1.57 in Vitamin D. The difference 
between average ranks of Cathelicidin and 
Chemerin are significantly different (p=0.04). 
Similarly the average ranks of Vitamin D and 
Cathelicidin are also significantly different 
(p<0.0001). However, no such relationship was 
observed between Vitamin D and Chemerin. We 
also observed a higher average rank for TNF 
cytokine (4.00) compared to other variables 
(p<0.0001). 
 
We next compared Cathelicidin and Chemerin 
levels in TB and EC groups. For this analysis, 
groups were divided in two categories of 
>median and ≤  median values of Cathelicidin 
(Fig 3A) and Chemerin (Fig 3B). The median 
value of Cathelicidin was 42.74 (IQR: 32.120-
78.650) in total study subjects. Fourteen of 
twenty two (14/22) (63.6%) TB patients had 
Cathelicidin level greater than 42.74 ng/ml 
compared to 5/17 (29.4%) of EC group. For 
≤median category, 12/17(70%) of EC had less 
than 42.72 ng/ml of Cathelicidin compared to 
8/22 (36%) in TB (Median test; p=0.03).  
 
Fig. 2. Distribution of antimicrobial peptide (cathelicidin), ad
vitamin D and TNF
Box plot shows the serum level of Chemerin
groups.  The results are shown as median, 25
The estimation of Chemerin, Cathelicidin
kits. Vitamin D was estimated by inhibition ELISA technique whe
regular ELISA. TNFα detection was carried out by in
antibodies.  Mann Whitney U test was applied for comparison of significant difference in two groups. P<0.05 was 
 
Fig. 3. Elevated level of 
The bar graph shows the proportion of TB and EC group in two categories of >
Cathelicidin (A) and Chemerin (B). X-axis sh
Y-axis shows the % in each category. All
test the proportion of subjects in two categories
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ipokine (chemerin), 
 in TB and EC groups 
(A), Cathelicidin(B), 25(OH)D3 (C), and TNFα (D) in TB and EC 
th
 and 75
th
 percentiles. Asterisks and circles are shown as outliers. 
 and vitamin D in blood was carried out by commercial sandwich ELISA 
re as Cathelicidin and Chemerin
-house Sandwich ELISA using pairs of monoclonal 
considered significant 
 
 
Cathelicidin but not Chemerin in TB patients
median and< median of 
ows the median categories of Cathelicidin and chemerinin ng/ml and 
 details of experiments are same as of Fig. 2. Median test was applied to 
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Table 1. Pairwise comparison of vitamin D, Cathelicidin, Chemerin and TNF in study  
subjects (n=39)  
 
Relationship between variables Average rank # Significance 
i. Vitamin D- Chemerin 1.57-1.95 0.311 
ii. Vitamin D- Cathelicidin 1.57-2.49 <0.0001 
iii. Vitamin D-TNF-  1.47-4.00 <0.0001 
iv. Chemerin- Cathelicidin 1.95-2.49 0.040 
v. Chemerin-TNF 1.95-4.00 <0.0001 
vi.  Cathelicidin - TNF 2.49-4.00 <0.0001 
# 
Friedman’s two-way analysis of variance by ranks 
 
The median value of Chemerin was 17.24 (IQR: 
10.13-54.34). TB group had 6/22(27%) of cases 
above the median value compared to 13/17 
(76%) of EC.  For ≤  median category, 16/22 
(72%) of TB had less than 17.24 ng/ml of 
Chemerin compared to only 3/17 (18%) in EC 
group (Median test, p=0.001). Median test for 
Vitamin D was not significant as it was observed 
that both groups were equally deficient for 
Vitamin D. These results show non homogenous 
distribution of two peptides in this study group. 
 
3.3 Correlation of Peptides (Cathelicidin 
and Chemerin) with Vitamin D and 
TNFα 
 
Fig. 4 shows the correlation of Vitamin D and 
Cathelicidin (A), Chemerin and Cathelicidin (B), 
TNFα and Cathelicidin (C) and TNFα and 
Chemerin (D). There was a negative correlation 
between Vitamin D and Cathelicidin (rho-0.189, 
p=0.248) and Vitamin D and Chemerin (rho-
0.132, p=0.430). Chemerin and Cathelicidin also 
showed no correlation (rho0.023, p=0.894).  
However, the numbers are fewer to draw a 
definitive conclusion about this relationship.  
TNFα showed a trend of positive correlation with 
Cathelicidin (rho0.367, p=0.033) and negative 
correlation with Chemerin (rho-0.191, p=0.287) 
and Vitamin D (rho-0.230, p=0.185).  The trend 
of positive correlation between TNFα and 
Cathelicidin indicates simultaneous regulation of 
both markers in inflammatory state. 
 
3.4 ROC Analysis for Biomarker of TB 
 
In order to assess the discriminatory power of 
markers in TB vs. EC groups, we carried out 
ROC analysis (Fig. 5). In ROC analysis, 
Cathelicidin was identified as most discriminatory 
marker with AUC of 0.780 (p=0.007), followed by 
TNFα (AUC of 0.673 (p=0.097). Both Vitamin D 
and Chemerin had no discriminatory power. This 
further confirms no relationship of Cathelicidin 
and Chemerin in TB disease. High level of 
Cathelicidin in TB patient was also shown in            
Fig. 2 with marginal significance compared to EC 
group (p=0.06). Cathelicidin is also emerging as 
a marker of acute inflammation in TB patients, 
which was also confirmed by ROC analysis             
(Fig. 5). 
 
To confirm an anti-inflammatory role of Vitamin 
D, we also performed whole blood stimulation 
assay with active form of Vitamin D [1,25-
(OH)2D3]. For this analysis, study group was 
divided in to three categories of Vitamin D and 
effect of stimulation of active form of Vitamin D 
was observed on IFNand IL10 cytokines. The 
results of whole blood assay showed an up 
regulation of IL-10 but not IFNin Vitamin D 
deficient group (Wilcoxon; p=0.04)                  
(suppl. Fig. 1).  
 
4. DISCUSSION 
 
The current study was carried out to delineate 
the relationship of two chemotactic and anti-
microbial peptides in TB and EC groups with 
similar level of Vitamin D deficiency.  
  
Chemerin and Cathelicidin have structural 
homology at N terminus region of hCAP18 [25].  
Both peptides are potent chemoattractant and 
possess antimicrobial activity against microbes 
[26].  The antibacterial activity was particularly 
exhibited by truncated peptides,  Chem S 157 
(truncated bioactive Chemerin lacking 6 amino 
acids) and S 155 against E. coli and K. 
pneumoniae [26]. These peptides also possess 
chemoattractant property for CMKLR1+ blood 
cells. Chemerin has been identified as a marker 
of pre-diabetic stage [27], whereas Cathelicidin 
as a marker of acute inflammation and probable 
biomarker of TB [28]. Vitamin D deficiency is 
prevalent worldwide including Pakistan [2].  
National Nutrition Survey of Pakistan 2011, 
reported a widespread deficiency of Vitamin D in  
Fig. 4. Correlation of biomarkers
Correlations of biomarkers are shown in scatter plot.  A) 
C) TNFα vs. Cathelicidin. D) TNFα vs. 
and curve lines are 95% CI among points lie close to linear line. 
both pregnant and non-pregnant women 
This deficiency was prevalent in both urban 
(87.9%) and rural (84.2%) women of child 
bearing age. Low serum Vitamin D was also 
correlated with Cathelicidin in sepsis patients 
and TB patients with smear positivity but
over all vitamin D status [7]. 
 
The increasing evidence of Vitamin D deficiency 
in both TB and diabetes has prompted us to 
investigate the actual relationship of markers of 
TB and Diabetes in context of Vitamin D.  To our 
knowledge, this is the first study in Pa
subjects delineating intricate relationship of 
Cathelicidin level with Chemerin in context of 
Vitamin D deficiency. The induction of 
Cathelicidin is dependent on sufficient level of 
active form of Vitamin D, which is also important 
for anti-mycobacterial activity of macrophages. 
However, our results showed no linear 
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Vitamin D vs. Cathelicidin. B) Chemerin 
Chemerin.  Straight lines indicate linear relationship between biomarkers 
The open and filled circles indicate EC and TB 
groups respectively 
 
[29]. 
[8] 
 not with 
kistani 
relationship between circulating inactive Vitamin 
D [25(OH) D3] and Cathelicidin peptide 
(Cathelicidin) (Fig. 4). This was also confirmed 
by ROC analysis where Cathelicidin showed up 
as a single marker to discriminate TB group from 
healthy controls with 80% sensitivity and 40% 
specificity.  Cathelicidin is also emerging as a 
new biomarker of TB disease [28
relationship of Cathelicidin with Vitamin D was 
also reported in TB patients, where high level of 
Cathelicidin was associated with high AFB 
positivity or disease severity [7]. 
was reported by Iacob et al. [30] in HCV infected 
patients. The other reports had conflicting results 
about correlation of Cathelicidin and Vitamin Din 
healthy controls [31,32]. Dixon et al reported 
positive correlation between Cathelicidin and 
Vitamin D using <32 ng/ml cutoff in healthy 
controls. In contrast to this, another report 
showed a positive correlation with Vitamin D, and 
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vs. Cathelicidin. 
]. A nonlinear 
Similar finding 
Fig. 5. ROC analysis of biomarkers
Receiver Operating Characteristic (ROC) analysis was performed on serum 
vitamin D (green): TB (n=20) was compared us
shown in yellow.  The dotted line shows the arbitrary cutoff for sensitivity and specificity of 
 
a trend of age dependent decrease in 
Cathelicidin. To confirm the role of Cathelicidin 
as a marker of inflammation, we also looked at 
TNFα in both study groups (TB and EC), which 
showed a direct linear relationship with 
Cathelicidin (Fig. 4D). 
 
Due to the ubiquitous expression of Chemerin in 
inflammatory and metabolic pathway, its 
regulation is broadly classified as agonists for 
nuclear receptors, and immuno-modulators for 
chronic inflammation. The pathway of Chemerin 
release is meant to be regulated by Vitamin D 
receptor (VDR) [33]. An increase in expression of 
Chemerin mRNA was observed when adipocytes 
were treated with Vitamin D [34]. Furthermore, 
high level of circulating immune mediator such as 
Chemerin and VCAM are highly  suggestive of 
inflammatory response in obese children with 
concurrent low vitamin D level [35]. 
results did not show such regulation of Chemerin 
and Vitamin D in our TB group, as both groups 
were deficient with Vitamin D but distribution of 
Chemerin was not homogenous in these groups. 
This relationship of Chemerin and Vitamin D 
holds true in case of inflammation of adipose 
Figure 5 
Iqbal et al.; BJMMR, 7(7): 611-622, 2015; Article no.
 
619 
 
 
 
 
Chemerin (brown), TNF
ing control (n=17) as non-disease state. The coordinate line is 
Cathelicidin
Although our 
tissue and fibroblast [34]. Based on our results, 
we speculate that inflammatory response of 
Chemerin is primarily due to inflammation in 
adipose tissue which differs from chronic 
inflammation in TB patients as level of Chemerin 
are significantly lower in lean TB group. 
 
In this study, we also studied the effect of 
exogenous addition of the active form of Vitamin 
D [1,25-(OH)2D3] in whole blood on the secretion 
of IFNand IL-10. Exogenous active form of 
Vitamin D stimulates anti-inflammatory cytokine
(IL-10) and down regulates pro
cytokine (IFN).  
 
Since there was no difference in Vitamin D level, 
therefore TB and EC group were pooled for 
invitro experiment. In our in vitro experiments, we 
found an anti-inflammatory effect of 1,25
(OH)2D3, that enhances the secretion of IL
while having a negative or no effect on 
IFNsecretion.  Bioactive Vitamin D[1,25
D3] has immunosuppressive effect on var
pro-inflammatory cytokines (IFN
[22,36], and exerts its regulatory effect on T cells 
via inhibition of DCs maturation [37
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The major limitation of our study was in 
accessibility of TB patient with co-morbid of 
Diabetes, which is critical to draw conclusion 
about role of Chemerin in TB with DM. The 
results of this study highlight the role of 
Cathelicidin as biomarker of TB which is also 
supported by concomitant increase in TNF in 
TB patient but not with Vitamin D and Chemerin.  
Vitamin D deficiency is prevalent in Pakistani 
population. Both TB patients and EC are 
deficient with circulating level of Vitamin D. This 
is interesting to investigate what factors in 
addition to Vitamin D increase susceptibility to 
TB infection, such as genetic, environmental and 
nutritional status.   
 
5. CONCLUSION 
 
Our results show a trend of nonlinear relationship 
of Cathelicidin and Chemerin in TB patients and 
healthy controls (EC) without comorbidity of DM.  
However, a linear relationship of Cathelicidin was 
observed with TNFα but not with Chemerin and 
Vitamin D. Cathelicidin was also identified as 
most discriminatory marker of inflammation in TB 
followed by TNFα. It is also important to study 
the relationship of these two peptides in TB 
patients with or without DM to further dissect the 
role of Chemerin and Cathelicidin in TB disease, 
and whether or not these markers can be used 
for screening TB with DM. 
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